Integrated medication dosing platform InsightRX has closed a $10 million Series A funding round headed by HealthX Ventures. Other participants in the round included Rock Health, OSF Healthcare, Leawood Venture Capital and Premier Inc., as well as returning backer GreatPoint Ventures.
According to the announcement, this brings the company’s total backing to $13 million.
WHAT THEY DO
Founded in...
Closed Loop Medicine cofounders (from left to right): Dr Paul Goldsmith, Dr Hakim Yadi, Dr Felicity Sartain, Dr David Cox
In recent years, it has become clear that the growing availability of health data and advances in genetics and technology are starting to support a shift away from the “one-size-fits-all” model for treating a condition, as we learn more about the impact of tailored medical interventions.
Let’s take one example. An area where new approaches will increasingly enable care to be managed according to...
Veronika Vartanova is a mobility researcher at Iflexion, a software development company based in Denver, Colorado. She writes on the latest trends in mobile app development, AR and VR business integration, and mobile-first digital transformation.
Wearables have come a long way from being merely entertaining to bringing in tangible health benefits.
Early on, bands with basic functionality were...
Above photo: Professor Krystyn Van Vliet (left) with a fellow researcher in the SMART CAMP laboratory performing confocal microscopic imaging of cells. Credit: SMART CAMP
The Singapore-MIT Alliance for Research and Technology (SMART), together with A*STAR Institutes and supported by the National Research Foundation (NRF), has launched a new national initiative dubbed Critical Analytics for Manufacturing Personalised-Medicine (CAMP). The initiative was launched as part of Singapore’s National Cell Manufacturing Initiative to overcome scientific and technical...
About the Authors: Joshua Barrett is a member of the 2019 Flare Capital Partners Scholar program and a third-year medical student at Georgetown University School of Medicine, who completed his MBA at the Columbia Business School. He plans to pursue a career in healthcare technology or life sciences investing.
Dr. Dan Gebremedhin (@dangebremedhin) is a partner at Flare Capital Partners, a...
The NIH’s All of Us Research Program celebrated its one-year anniversary today with new updates on enrollment progress, previews of its upcoming cloud-based data platform for health researchers and the public beta launch of an online tool for viewing aggregated, de-identified information about the program’s enrollees.
“I hoped [one year ago] that many would share this vision and help us achieve...
Awareness of personalized medicine and treatment is slowly, but gradually, on the rise, according to the results of a recent survey polling 1,000 consumers published by automated dosage platform maker Dosis.
What’s more, older consumers are the most likely demographic to have some awareness of personalized medicine, as well as the first to admit that their prescriptions are not adequately...
Concerto HealthAI, the maker of a clinical insight generation platform that employs real-world data in its analyses, is racking up the pharma partnerships as of late. Just weeks after the artificial intelligence company agreed to a multi-year deal with Bristol-Myers Squibb, Concerto announced this morning a similar project with Pfizer that will support the latter’s research on precision oncology...
Moshe Bar Siman-Tov speaks at MedInIsrael 2019 in Tel Aviv. Photo by Roy Habani.
With a population of just 9 million, Israel is not a large country. But its contributions to health innovation, in particular digital health, are outsized. The country boasts 500 digital health startups as well as hospitals like Sheba Medical Center, which has recently been ranked in the top 10 in the world by Newsweek.
What does the country have going for it? A mostly interoperable, fully...
Prof. Boaz Lerner of Ben-Gurion University with the new platform for predicting ALS progression. Credit: BGU
BGN Technologies, the technology transfer company of Ben-Gurion University (BGU), today unveiled an artificial intelligence (AI) platform for monitoring and predicting the progression of neurodegenerative diseases for the purpose of identifying markers for personalised patient care and improved drug development.
Developed by Prof. Boaz Lerner of the Department of Industrial Engineering and...
